Delving into the Latest Updates on ShaanXi Hanwang Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Otorhinolaryngologic Diseases

Nervous System Diseases

Endocrinology and Metabolic Disease

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Herbal medicine	1

The ethanol extraction and membrane separation process of flavonoids from Ginkgo biloba leaves were studied, and the process conditions were optimized as follows: extracting Ginkgo biloba leaves for2 h at 80 °C and ratio of material to solvent 1 : 10 with 70% ethanol, then separated and purified by a gradient membrane device composed of ceramic membranes with relative mol. weights of 30 000, 10 000 and 5 000 under the conditions of the pressure 0. 25 MPa, temperature 30 °C and time 120 min, and the flavonoid transmission rate was 94. 22%, and the content of flavonoids in the product was45. 60% after membrane separation

100 Deals associated with ShaanXi Hanwang Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with ShaanXi Hanwang Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 02 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data